Why Did Firm Keep Selling Problem Blood-Clot Filters?

A medical device company that created a blood-clot filter has been found to be associated with 27 deaths and hundreds of serious problems. To answer the issues, the company replaced the device with a modern modified version that was known to have similar and potentially life threatening flaws soon after it was put on the market.

Company records confidentially obtained by NBC News show that the well known New Jersey-based medical device giant C.R. Bard was knowingly concerned about reports of failures for its G2 series filters. These filters were designed to replace the company’s popular Recovery filter, within four months of being cleared to sell the G2 by the Food and Drug Administration.

However, instead of recalling the G2 filter and the about identical G2 Express, the medical device manufacturer C.R. BARD decided to keep them on the market for five years, until 2010, selling more than 160,000 of them. This resulted in at least 12 deaths and hundreds of problems are now linked to the G2 series filters. All this is according to Bard and FDA records.

Read NBC News’ original reports on the Recovery filter here and here.

If you feel like you have been wronged by a BARD G2 filter and have any questions about your injuries and what you can do, simply contact us today to see if you are qualified for a cash settlement.